10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
On February 6, 2020, Governor Andrew Cuomo signed an amendment to New York Labor Law § 592 that redu...
Read More >
In the wake of the impeachment proceedings, the State of the Union, the Administration’s budget pro...
Read More >
On July 23, 2020, the California Transportation Foundation convened a panel of transportation profes...
Read More >
The panels were moderated by partners Sally Yates from the firm’s Atlanta office and Michael Ursche...
Read More >
The President revoked Executive Order (E.O.) 13495, which required successor contractors to offer se...
Read More >
As of September 11, 2019, the California Senate and Assembly had both passed an employment bill (AB5...
Read More >